ClinConnect ClinConnect Logo
Search / Trial NCT06910527

Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients

Launched by POULET GEOFFROY · Apr 2, 2025

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Kidney Transplantation Cell Free Dna Epigenetic

ClinConnect Summary

This clinical trial is studying how to detect kidney transplant rejection by examining DNA from the blood and urine of kidney transplant patients. When a transplant is rejected, the body releases DNA from the donor kidney into the bloodstream. Researchers want to see if they can use a new technology to measure this DNA accurately, which could help identify and understand transplant rejection earlier.

To be eligible for this study, participants must be kidney transplant recipients who are suspected of having a rejection episode and need a specific test called a renal biopsy. Unfortunately, people with certain cognitive or mental health issues, or those unable to give their consent, cannot participate. If you join the study, you can expect to provide blood and urine samples, which will help researchers learn more about how to monitor transplant health. This trial aims to improve the care for kidney transplant patients by offering better ways to detect when their transplant is in trouble.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients living with a kidney transplant
  • Admitted for suspected transplant rejection requiring a renal biopsy (RBB) as an indication
  • Exclusion Criteria:
  • Patients with cognitive and mental disorders rendering them unable to express their non-opposition to participation in the study
  • Not covered by a social security system.
  • Under guardianship or guardianship, or under legal protection.
  • Patients who have expressed their refusal to participate in the study

About Poulet Geoffroy

Poulet Geoffroy is a leading clinical trial sponsor dedicated to advancing medical research and enhancing patient care through innovative therapeutic solutions. With a strong emphasis on collaboration and integrity, the organization orchestrates and manages clinical trials across various therapeutic areas, ensuring compliance with regulatory standards and ethical guidelines. Leveraging a robust network of healthcare professionals and research institutions, Poulet Geoffroy is committed to delivering high-quality data that supports the development of safe and effective treatments, ultimately aiming to improve health outcomes for diverse patient populations.

Locations

Rouen, , France

Patients applied

0 patients applied

Trial Officials

Geoffroy GP POULET, PhD

Study Director

CGenetix

TRISTAN DE NATTES, MEDICAL DOCTOR

Principal Investigator

CHU ROUEN UNIVERSITY

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported